Financials

  • Market Capitalization 432.36 M
  • Employee 38
  • Founded 2012
  • CEO N/A
  • Website www.quincetx.com
  • Headquarter Delaware, United States
  • FIGI BBG00BTK1DT8
  • Industry N/A
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
6938
TRXB
TRex Bio, Inc. Common stock
10.31 USD+6.07%-26.04%-33.27%-23.63%296.81 M USD
6939
ACMG
60.3010 USD-4.44%-6.89%-11.76%-15.92%0 USD
6941
AXNX
Axonex AI Group Limited Class A Ordinary Shares
0.8300 USD-8.29%-14.43%-28.45%+2.74%21.09 M USD
6942
RNTZ
Rantizo Class A Ordinary Shares
3.72 USD-7.00%-13.49%-19.31%-16.59%69.75 M USD

Frequently asked questions about IRulya Therapeutics Inc. Common Stock

What is the IRulya Therapeutics Inc. Common Stock stock price today?

The current price of IRulya Therapeutics Inc. Common Stock (IRLA) is 39.88. Over the past 24 hours, the stock has changed by -0.15%. Follow the IRLA chart for real-time price dynamics.

What is the stock ticker of IRulya Therapeutics Inc. Common Stock?

IRulya Therapeutics Inc. Common Stock trades under the ticker IRLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is IRulya Therapeutics Inc. Common Stock stock going up?

IRLA has changed by -7.41% over the last week, +11.71% over the last month, and +41.57% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of IRulya Therapeutics Inc. Common Stock?

IRulya Therapeutics Inc. Common Stock currently has a market capitalization of 432.36 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were IRulya Therapeutics Inc. Common Stock earnings last quarter?

Last quarter, IRulya Therapeutics Inc. Common Stock reported earnings of -2.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was IRulya Therapeutics Inc. Common Stock revenue for the last quarter?

IRulya Therapeutics Inc. Common Stock reported quarterly revenue of 1.73 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was IRulya Therapeutics Inc. Common Stock net income for the last quarter?

IRulya Therapeutics Inc. Common Stock reported net income of -27.74 M for the last quarter. The previous quarter showed -75.49 M, which means net income changed by +63.25%.

How many employees does IRulya Therapeutics Inc. Common Stock have?

As of the latest available data, IRulya Therapeutics Inc. Common Stock has 38 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy IRulya Therapeutics Inc. Common Stock stock?

You can buy IRulya Therapeutics Inc. Common Stock (IRLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in IRulya Therapeutics Inc. Common Stock stock?

Investing in IRulya Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IRLA chart and related analysis on metatrader.com as part of your research.